TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 SEK)
| Closing information | 2022/08 | 2021/08 | 2020/08 |
| Turnover |
804
|
699
|
706 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
73
|
11
|
3 |
| EBITDA |
73
|
11
|
3 |
| Total assets |
504
|
440
|
422 |
| Current assets |
504
|
440
|
422 |
| Current liabilities |
169
|
169
|
162 |
| Equity capital |
335
|
271
|
260 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/08 | 2021/08 | 2020/08 |
| Solvency |
66.5%
|
61.6%
|
61.6% |
| Turnover per employee |
804
|
699
|
706 |
| Profit as a percentage of turnover |
9.1%
|
1.6%
|
0.4% |
| Return on assets (ROA) |
14.5%
|
2.5%
|
0.7% |
| Current ratio |
298.2%
|
260.4%
|
260.5% |
| Return on equity (ROE) |
21.8%
|
4.1%
|
1.2% |
| Change turnover |
105
|
-7
|
-59 |
| Change turnover % |
15%
|
-1%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/08 | 2021/08 | 2020/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.